HEALWELL AI Closes the $25.5M Equity Tranche of Its Upsized Bought Deal Financing
Toronto, Ontario--(Newsfile Corp. - January 21, 2025) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative care, is pleased to announce that it has completed the first
2025-01-21 11:41 AM EST
HEALWELL AI Receives Written Shareholder Approval for Pending Acquisition of Orion Health and Related Financing
Toronto, Ontario--(Newsfile Corp. - January 14, 2025) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative care, is pleased to announce that it has obtained sharehold
2025-01-14 3:15 AM EST
HEALWELL Acquires Control of Mutuo Health Solutions to Build Next Generation of AI-Powered Physician Co-Pilots
HEALWELL has acquired a majority controlling interest in Mutuo Health Solutions, a Toronto-based medical artificial intelligence company focused on developing predictive clinical AI technology. Mutuo Health's AutoScribe platform is an advanced AI-powered ambient scribe solution that transcribes clinician-patient interactions into high-quality electronic medical records in real time using natural language processing and machine learning technology. AutoScribe's speech recognition capabilities,...
2024-12-03 3:15 AM EST
HEALWELL's VeroSource Solutions Provides Corporate Update Demonstrating Rapid Growth and Expansion Across Canadian Public Sector Clients
More than 600,000 New Brunswick residents are now eligible to generate a Patient Summary on the VeroSource-built MyHealthNB digital front door. This year, MyHealthNB averaged over 35,000 unique monthly users in New Brunswick, reflecting 100% growth compared to 2023. The VeroSource-managed Saskatchewan Health Authority website was accessed by patients and providers over 1.3 million times in 2024, representing a 50% increase in traffic from the previous year. In addition to its successful...
2024-11-27 3:15 AM EST
HEALWELL AI Appoints Beatrice York, Dr. Marcel Reichart, and Reeva Misra to Strategic Advisory Board
Toronto, Ontario--(Newsfile Corp. - November 19, 2024) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), an AI and data science company focused on preventative care, is pleased
2024-11-19 3:15 AM EST
HEALWELL Reports Record Revenue and Increased Customer Activity from Pharmaceutical Partners in Q3-2024
HEALWELL achieved record quarterly revenue from continuing operations of $13.7 million in Q3-2024, 738% higher than the $1.6 million generated in Q3-2023 and 153% higher than the $5.4 million generated in Q2-2024. Quarterly revenues were driven by HEALWELL completing the acquisitions of BioPharma Services Inc. and VeroSource Solutions Inc. during Q3-2024. Management maintains a positive outlook and based on current M&A pipeline continues to expect to make further M&A announcements by year-end...
2024-11-12 5:00 AM EST
HEALWELL's Pentavere Receives Prestigious Prix Galien USA 2024 Award for Best Digital Health Startup for Its Contributions in AI for Life Sciences Industry
The Prix Galien Award is among the global health innovation industry's most renowned honors, recognizing outstanding biomedical, medical, and technology achievements that improve the human condition and is considered the industry's equivalent of the Nobel Prize. Pentavere's DARWEN™ AI platform was awarded for its proven contribution in making healthcare more accessible and personalized for patients and for using various forms of AI including generative AI to help identify patients and detect...
2024-11-12 3:15 AM EST
HEALWELL Provides Corporate Update on Accelerating Commercialization and Expansion of Pharmaceutical Partnerships by Leveraging Its Best-in-Class Patient Identification Capabilities
HEALWELL's AI and data science subsidiaries have executed 5 new Master Services Agreements ("MSA") with new pharmaceutical partners in Q3-2024; bringing the total number of MSAs with life sciences partners to 27, which includes 6 of the top 10 pharmaceutical companies in the world. HEALWELL's AI and data science subsidiaries generated patient identification revenue from 23 of these pharmaceutical partners in Q3-2024. HEALWELL subsidiary, Khure Health, has executed an MSA for patient...
2024-11-05 3:15 AM EST
HEALWELL AI to Announce Third Quarter 2024 Financial Results on November 12, 2024
Toronto, Ontario--(Newsfile Corp. - November 4, 2024) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare technology company focused on AI and data science for preventative care, is pleased to announce the Company will release its Fiscal Third Quarter 2024 financial results for the period ended September 30, 2024, on Tuesday, November 12, 2024. The Company will hold a conference call and simultaneous webcast to discuss its results on the same day at 1:00...
2024-11-04 4:15 PM EST
WELL Health and HEALWELL AI Expand Strategic Alliance Agreement to Develop an AI-Enhanced Clinical Trials Program to Accelerate Innovation and Improve Patient Outcomes
WELL Health and HEALWELL AI announce the expansion of their multi-year agreement that allows WELL and HEALWELL to launch and manage clinical trial sites at WELL Health clinic locations across Canada. Leveraging HEALWELL's Contract Research Organization (CRO) capabilities alongside WELL Health's network of clinics across Canada, positions the partnership as a formidable player in AI-driven clinical trials, and opens up new revenue streams. This partnership allows HEALWELL AI to offer an...
2024-10-29 3:15 AM EDT
HEALWELL AI Announces Strategic Investment and Commercialization Agreement with Abstractive Health to Advance Generative AI-Powered Clinical Documentation Solutions
HEALWELL AI completes a strategic investment in NY-based Abstractive Health, alongside lead investor Rho Capital Partners, to support the development of AI-driven clinical documentation technology. Concurrent with the investment, HEALWELL also entered into a commercial agreement with Abstractive Health that provides HEALWELL with exclusive distribution rights to the Canadian outpatient healthcare market. Abstractive Health's AI software leverages LLMs and other generative AI technology to...
2024-10-22 5:00 AM EDT
BioPharma Services Announces Expansion into Late-Stage Patient Trials and Integration with HEALWELL's Artificial Intelligence Platform Capabilities to Become a Full-Service Next Generation CRO
HEALWELL's subsidiary, BioPharma Services, is expanding into late-stage patient trials through the integration of Canadian Phase Onward, a dedicated clinical research site built within the framework of HEALWELL's Polyclinic Family and Specialty Medicine Facility. This strategic integration is a significant milestone, enhancing BioPharma's ability to manage clinical trials across all phases of drug development and making the business a full-service Contract Research Organization. The move also...
2024-09-19 3:15 AM EDT
HEALWELL AI's Pentavere Nominated for 2024 Prix Galien Award, a Prestigious Award, for Its Contributions in AI for Life Sciences and Announces Participation at Key Medical Conferences
Pentavere is nominated for a 2024 Prix Galien Award for its contributions in AI and data science benefiting the human condition. The award is offered by the Galien Foundation and considered the most prestigious of all honours in the life sciences and pharmaceutical industry which is regularly awarded to recipients who are believed to have had the greatest impact on human health. This is Pentavere AI's third Prix Galien nomination in 3 years for the Best Digital Health Startup category. To...
2024-09-05 3:15 AM EDT
WELL Health's OceanMD and HEALWELL's Intrahealth Announce Partnership to Expand Access to eReferral Healthcare Solutions
British Columbia and Toronto, Ontario--(Newsfile Corp. - August 22, 2024) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF)
2024-08-22 7:15 AM EDT
HEALWELL AI Reports Record Revenue and a Healthy Balance Sheet in Q2-2024
HEALWELL achieved record quarterly revenue from continuing operations of $5.44 million in Q2-2024, 205% higher than the $1.78 million generated in Q2-2023 and 19% higher than the $4.58 million generated in Q1-2024. HEALWELL also reported net income of $2.54 million as compared to a loss of $9.81 million in Q2 2023. This was primarily due to the successful removal and settling of a significant number of liabilities incurred in past years. Management maintains a positive outlook, with...
2024-08-12 4:50 PM EDT
HEALWELL AI to Announce Fiscal Second Quarter 2024 Financial Results on August 12, 2024
Toronto, Ontario--(Newsfile Corp. - August 7, 2024) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), an AI and data science company focused on preventative care, is pleased to announce the Company will release its Fiscal Second Quarter 2024 financial results for the period ended June 30, 2024, on Monday, August 12, 2024. The Company will hold a conference call and simultaneous webcast to discuss its results on the same day at 5:30 pm EST (2:30 pm PST). The call...
2024-08-07 4:15 PM EDT
HEALWELL's Intrahealth Announces Patient Management Contract with the New Zealand Department of Corrections
Toronto, Ontario--(Newsfile Corp. - July 31, 2024) - HEALWELL AI Inc. (TSX: AIDX, OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare technology company focused on AI and data science for preventative care, is pleased to announce its subsidiary, Intrahealth, a leading technology solutions provider specializing in electronic health records, has partnered with the New Zealand Department of Corrections to improve offender healthcare through the delivery of a new patient management system. Do
2024-07-31 3:15 AM EDT
Province of New Brunswick Launches New Patient Summary with HEALWELL AI's VeroSource Solutions
VeroSource, a subsidiary of HEALWELL, built the new Patient Summary feature that launched on the MyHealthNB mobile app in partnership with Canada Health Infoway and the Government of New Brunswick. The Patient Summary feature allows users to create a summary of their medical information including medications, immunizations, lab results and imaging reports, which can then be securely shared with healthcare professionals and care providers. By enabling the secure sharing of personal health...
2024-07-25 3:15 AM EDT
HEALWELL AI Provides Corporate Update on Capital Allocation Program and Value Creation Strategy
HEALWELL's current goal is to achieve run rate revenues approaching $100 million by the end of the year from today's current run rate of over $65 million. This goal is underpinned by a robust M&A pipeline where there are several advanced subjects including one signed LOI and helps the Company position itself to achieve profitability on an Adjusted EBITDA basis in 2025. HEALWELL's four acquisitions to date have positioned the company to unlock the power of health data with artificial...
2024-07-23 3:15 AM EDT
WELL Health Launches its AI-powered Co-pilot for Cardiologists powered by HEALWELL AI to Help Improve Detection of Cardiovascular Disease
WELL has launched its new AI-powered physician co-pilot to assist cardiologists in better identifying patients at high risk of cardiovascular disease ("CVD"). WELL is exclusively partnering with HEALWELL AI, a leader in AI enabled disease diagnosis, as an extension of the WELL AI Decision Support ("WAIDS") product offering. The co-pilot will be deployed into WELL Diagnostic Centres, Canada's largest cardiology and medical diagnostic group, providing support and assisting cardiologists in over...
2024-07-17 3:15 AM EDT